Toggle light / dark theme

Clearing the brain of aging cells could aid epilepsy and reduce seizures

Temporal lobe epilepsy, which results in recurring seizures and cognitive dysfunction, is associated with premature aging of brain cells.

A new study by researchers at Georgetown University Medical Center found that this form of epilepsy can be treated in mice by either genetically or pharmaceutically eradicating the aging cells, thereby improving memory and reducing seizures as well as protecting some animals from developing epilepsy.

The study appears in the journal Annals of Neurology.

CRISPR screen uncovers hundreds of genes required for brain development

Which genes are required for turning embryonic stem cells into brain cells, and what happens when this process goes wrong? In a new study published today in Nature Neuroscience, researchers led by Prof. Sagiv Shifman from The Institute of Life Sciences at The Hebrew University of Jerusalem, in collaboration with Prof. Binnaz Yalcin from INSERM, France, used genome-wide CRISPR knockout screens to identify genes that are needed for early brain development.

The study set out to answer a straightforward question: which genes are required for the proper development of brain cells?

Using CRISPR-based gene-editing methods, the researchers systematically and individually “switched off” roughly 20,000 genes to study their role in brain development. They performed the screen in embryonic stem cells while the cells changed into brain cells. By disrupting genes one by one, the team could see which genes are required for this transition to proceed normally.

Viral mimicry in cancer therapy

Transposable elements in cancer therapy.

Transposable elements (TEs) are a major source of immunogenic nucleic acids that can be therapeutically reactivated in cancer cells to induce a state of viral mimicry.

TE expression can trigger innate immune sensing pathways, including type I interferon responses, and promote immunogenic cell death via sensors such as RIGI, MDA5, cGAS, and Z-DNA binding protein 1.

Although initially described in the context of epigenetic therapies, viral mimicry is now recognized as a shared response to diverse cancer treatment modalities, including chemotherapies and targeted therapies.

Despite their distinct primary mechanisms, these treatments converge on TE reactivation through disruption of DNA/histone methylation, p53 activation, and perturbation of mRNA splicing.

Therapeutic resistance to chemotherapy, radiation, and targeted agents is associated with TE silencing, identifying TE repression as a targetable axis of resistance.

Combination strategies to induce immunogenic TE expression can further enhance viral mimicry and boost antitumor immunity. https://sciencemission.com/Viral-mimicry-in-cancer-therapy

A key Alzheimer’s gene emerges in African American brain study

Scientists studying Alzheimer’s in African Americans have uncovered a striking genetic clue that may cut across racial lines. In brain tissue from more than 200 donors, the gene ADAMTS2 was significantly more active in people with Alzheimer’s than in those without it. Even more surprising, this same gene topped the list in an independent study of White individuals. The discovery hints at a common biological pathway behind Alzheimer’s and opens the door to new treatment strategies.

CRISPR vs Aging: What’s Actually Happening Right Now

🧠 VIDEO SUMMARY:
CRISPR gene editing in 2025 is no longer science fiction. From curing rare immune disorders and type 1 diabetes to lowering cholesterol and reversing blindness in mice, breakthroughs are transforming medicine today. With AI accelerating precision tools like base editing and prime editing, CRISPR not only cures diseases but also promises longer, healthier lives and maybe even longevity escape velocity.

0:00 – INTRO — First human treated with prime editing.
0:35 — The DNA Problem.
1:44 – CRISPR 1.0 — The Breakthrough.
3:19 – AI + CRISPR 2.0 & 3.0
4:47 – Epigenetic Reprogramming.
5:54 – From the Lab to the Body.
7:28 – Risks, Ethics & Power.
8:59 – The 2030 Vision.

👇 Don’t forget to check out the first three parts in this series:
Part 1 – “Longevity Escape Velocity: The Race to Beat Aging by 2030″
Part 2 – “Longevity Escape Velocity 2025: Latest Research Uncovered!“
Part 3 – “Longevity Escape Velocity: How AI is making us immortal by 2030!”

📌 Easy Insight simplifies the future — from longevity breakthroughs to mind-bending AI and quantum revolutions.

🔍 KEYWORDS:
longevity, longevity escape velocity, AI, artificial intelligence, quantum computing, supercomputers, simplified science, easy insightm, CRISPR 2025, CRISPR gene editing, CRISPR cures diseases, CRISPR longevity, prime editing 2025, base editing 2025, AI in gene editing, gene editing breakthroughs, gene therapy 2025, life extension 2025, reversing aging with CRISPR, CRISPR diabetes cure, CRISPR cholesterol PCSK9, CRISPR ATTR amyloidosis, CRISPR medical revolution, Easy Insight longevity.

👇 JOIN THE CONVERSATION:

Bacteria reveal second ‘shutdown mode’ for surviving antibiotic treatment

A new study reveals that bacteria can survive antibiotic treatment through two fundamentally different “shutdown modes,” not just the classic idea of dormancy. The paper is published in the journal Science Advances.

The researchers show that some cells enter a regulated, protective growth arrest, a controlled dormant state that shields them from antibiotics, while others survive in a disrupted, dysregulated growth arrest, a malfunctioning state marked by vulnerabilities, especially impaired cell membrane stability. This distinction is important because antibiotic persistence is a major cause of treatment failure and relapsing infections even when bacteria are not genetically resistant, and it has remained scientifically confusing for years, with studies reporting conflicting results.

By demonstrating that persistence can come from two distinct biological states, the work helps explain those contradictions and provides a practical path forward: different persister types may require different treatment strategies, making it possible to design more effective therapies that prevent infections from coming back.

Inferring intrinsic neural timescales using optimal control theory

Here, the authors develop novel dynamical methods to model brain regions’ intrinsic neural timescales (INTs) from data, and find that they couple whole-brain structural connectivity to dynamic switching between brain activity states, and correlate with genetic markers.

Why Your Lifespan Could Be Thousands of Years — New DNA Research Explained

Can humans live for thousands of years? New DNA and longevity research suggests that aging may not be fixed—it may simply be the result of imperfect cellular repair. In this video, we explore how DNA damage, genetic repair mechanisms, and modern longevity science are reshaping our understanding of human lifespan.

This content is based on current research from USA and Europe, focusing on emerging breakthroughs in genetics, DNA repair therapies, and anti-aging science.
If you’re interested in health, biology, or the future of human longevity, this video is for you.

Disclaimer:
This video is for educational purposes only, is not intended to diagnose, treat, or cure any condition, and does not replace professional medical advice. Always consult a qualified healthcare provider for guidance related to your health.

#LongevityScience.
#DNARepair.
#AntiAging.
#GeneticsResearch.
#HealthFacts.
#BioLogicHealth.
#ScienceExplained.
#HealthyAging

A mother’s circadian rhythm may predict her child’s vulnerability to bacterial infection

In laboratory models, researchers at The University of Texas MD Anderson Cancer Center discovered that a mother’s circadian rhythms, or internal body clock, can influence the immune system states of her offspring, which can accurately predict the risk of bacterial infection.

These findings offer novel insights into non-genetic factors shaping immune defenses and provide a framework to study circadian rhythms as a possible reason why some patients might be more vulnerable to getting infections during disease treatment. The study, published in Science Advances, was led by Alejandro Aballay, Ph.D., professor of Genetics and dean of the UTHealth Houston Graduate School of Biomedical Sciences.

“These findings reveal a circadian mechanism that can create significant differences in infection outcomes even when genetics and environment are similar,” Aballay said. “This circadian control may help explain why patients with comparable risk profiles often experience very different responses to infection.”

Melanoma cancer cells secrete extracellular vesicles to paralyze immune cells

A new international study led by Prof. Carmit Levy of the Department of Human Genetics and Biochemistry at the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds that melanoma cancer cells paralyze immune cells by secreting extracellular vesicles (EVs), which are tiny, bubble-shaped containers secreted from a given cell. The research team believes that this discovery has far-reaching implications for possible treatments for the deadliest form of skin cancer.

The work is published in the journal Cell.

Melanoma is the deadliest type of skin tumor. In the first stage of the disease, melanocytic cells divide uncontrollably in the skin’s outer layer, the epidermis. In the second stage, the cancer cells invade the inner dermis layer and metastasize through the lymphatic and blood systems.

/* */